Status:

RECRUITING

Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment

Lead Sponsor:

AUSL Romagna Rimini

Collaborating Sponsors:

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Conditions:

Non-Small Cell Lung Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is an interventional, non-pharmacologic, randomized controlled study evaluating the impact on quality of life of a personalized exercise program in oncogene addicted lung cancer patients undergoi...

Detailed Description

This is an interventional, non pharmacological, randomized controlled trial evaluating the impact on quality of life of a personalized exercise program in oncogene addicted lung cancer patients underg...

Eligibility Criteria

Inclusion

  • Age 18 years or older
  • Willingness to provide written informed consent.
  • Life expectancy \>12 weeks.
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.
  • Body massa index \> 18.
  • Oncogene-addicted (EGFR, ALK, ROS1, RET, BRAF) stage IV or III b not suitable for local treatment receiving first- or second-line systemic treatment (palliative radiotherapy and prior chemotherapy allowed). Patients undergoing treatment in clinical trials are excluded.

Exclusion

  • Inability to walk.
  • Immobility for more than 3 days before study enrollment.
  • Previously untreated (non-irradiated or non-resected) symptomatic brain metastases.
  • Severe cardiac impairment (e.g. cardiac insufficiency New York Heart Association (NYHA) \> III, myocardial infarction within the last three months, severe cardiac arrhythmias, high grade aortic stenosis).
  • Severe respiratory failure.
  • Uncontrolled pain.
  • Bone metastasis inducing increased risk of pathological fractures.

Key Trial Info

Start Date :

April 4 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT05306652

Start Date

April 4 2022

End Date

June 1 2026

Last Update

May 31 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

S.Maria delle Croci Hospital, Oncology Unit

Ravenna, Italy